Q1 2025 Evolent Health Inc Earnings Call Transcript
Key Points
- Evolent Health Inc (EVH) reported Q1 financial results at the high end of expectations, indicating a strong start to 2025.
- The company secured five new revenue agreements in Q1, expanding its reach in specialty condition management.
- Evolent Health Inc (EVH) successfully renewed a major contract with one of its top 10 customers through 2030, showcasing strong customer retention.
- The Performance Suite pipeline is the largest in the company's history, indicating robust demand for its solutions.
- Evolent Health Inc (EVH) is making significant progress in AI-led automation, enhancing clinician satisfaction and productivity.
- Revenue was impacted by contractual changes, resulting in a shift from gross to net accounting for two Performance Suite contracts.
- The company experienced a retroactive revenue impact of minus $12.9 million due to final capitation rate adjustments.
- Evolent Health Inc (EVH) anticipates a modest increase in net debt across the April to December period.
- The oncology cost trend is running below the expected 12%, but the company has not yet adjusted its guidance to reflect this.
- Potential policy changes, such as Medicaid work requirements, could impact adjusted EBITDA by $8 million to $10 million.
Welcome to the Evolent Health conference call for the first quarter ended March 31, 2025.
As a reminder, this conference call is being recorded.
Your host for the call, today, from Evolent are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer.
This call will be archived and available later this evening and for the next week, via the webcast on the company's website in the section titled Investor Relations.
This conference call will contain forward-looking statements, under the US Federal law. These statements are subject to risks and uncertainties that could cause actual results to differ, materially, from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the company's reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings.
For additional information on the company's results and outlook, please refer to our first-quarter press release, issued earlier today.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
